AHR 2016: The aryl hydrocarbon receptor as a central mediator of health and disease

AHR 2016：芳烃受体作为健康和疾病的中心介质

• 批准号: 9121735
• 负责人: B Paige Lawrence
• 金额: $ 1万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-01 至 2017-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9121735
• 关键词: Address; Applied Research; Area; Aryl Hydrocarbon Receptor; Attention; Basic Science; Biological Process; Clinical; Clinical Medicine; Collaborations; Communities; Consensus; Development; Developmental Biology; Disabled Persons; Disadvantaged; Discipline; Disease; Doctor of Philosophy; Ensure; Environmental Health; Environmental Medicine; Environmental Pollution; Fertilization; Fostering; Foundations; Funding; Future; Germany; Goals; Grant; Health; Human; Immunology; Interdisciplinary Communication; International; Knowledge; Ligands; Mediator of activation protein; Minority; Minority Groups; Molecular; National Institute of Environmental Health Sciences; Oral; Output; Participant; Personal Satisfaction; Pharmacology; Pharmacy (field); Postdoctoral Fellow; Public Health; Publishing; Regulation; Request for Applications; Research; Research Personnel; Research Priority; Role; Science; Scientist; Source; Students; Thinking; Toxic effect; Toxicology; Universities; Woman; abstracting; aryl hydrocarbon receptor ligand; base; improved; interest; meetings; multidisciplinary; posters; prevent; programs; public health relevance; rapid growth; symposium; translational approach

 DESCRIPTION (provided by applicant): This application requests funds to support an international conference entitled "AHR 2016: The aryl hydrocarbon receptor as a central mediator of health and disease" which will be in Rochester, NY in August 3-6, 2016. Specifically, funds from this R13 application to the NIEHS will be used to support disadvantaged poorly represented and/or junior investigators who submit research abstracts and wish to participate in the meeting, but who otherwise might not be able to attend. Their participation will undoubtedly strengthen the conference and the field as a whole. This conference covers a topic that is highly relevant to toxicology and environmental health sciences, and which is also gaining tremendous attention from other sectors, including basic immunology, developmental biology, pharmacology, and pharmaceutics. However, there are no regular (or as far as we know, planned) scientific conferences focused solely on the AHR. Given the rapid but poorly integrated advancements in the field, there is pressing need to bring together toxicologists, basic biologists, and clinical/translational researchers who are all interested in the AHR and its many ligands? Therefore, in addition to fostering the participation of junior investigators, women, minority groups, and the disabled, other goals of this conference include the following: promoting greater interactions among scientists of diverse backgrounds; creating the opportunity to discuss cutting-edge science, and building the foundation for cross- disciplinary communication and collaborations to advance the field. This conference will advance the pace of science by identifying key knowledge gaps and developing strategies to address them, pinpointing critical implications for environmental health and clinical medicine, and building consensus for addressing specific research priorities that relate to these issues. As a consequence of these goals, the meeting is expected to promulgate cutting-edge information that will catalyze new discoveries to improve health and well-being. Also, as a more tangible output, the Organizing Committee plans to develop a review article to be submitted after this conference. Based upon meeting attendance, presentations, and discussion, the organizers will assess the potential for a more expanded set of research and/or review articles based on this conference, as well as evaluate the potential for a future conference on this topic.

 描述（由应用程序提供）：本申请要求资金支持题为“ AHR 2016：芳基碳氢化合物接收器作为健康与疾病的中央核心中介人”，该会议将于2016年8月3日至6日在纽约州罗切斯特，具体来说，具体来说，该R13的申请将用于支持灾难的较差的人，以支持灾难的研究人员，以供参与者参与其中，以供参与者参与，以供参与者参与其中，以便参与参与者的研究人员，这些人的参与者及其参与者的参与者，这些人的参与者及其参与者的参与者，这些人的参与者及其参与者的参与者，这些人的参与者及其参与者的研究人员，这些人的参与者及其参与者的统治者，这些申请的参与者和参与者的参与者及无法参加。他们的参与无疑将加强会议和整个领域。该会议涵盖了一个与毒理学和环境健康科学高度相关的主题，并且还引起了其他部门的极大关注，包括基本的免疫学，发育生物学，药理学和药物。但是，没有普通的（或据我们所知，计划的）科学会议仅关注AHR。鉴于该领域的迅速但综合性的进步迅速，需要将毒理学家，基本生物学家和临床/翻译研究人员汇集在一起​​，他们对AHR及其许多配体感兴趣？因此，除了培养初级调查人员，妇女，少数群体和残疾人的参与外，本次会议的其他目标还包括：促进不同背景科学家之间的更大互动；创造了讨论尖端科学的机会，并为跨学科的沟通和合作建立基础，以推动这一领域。这次会议将通过确定关键知识差距和制定解决方案的策略来提高科学的速度，从而确定对环境健康和临床医学的关键影响，并建立共识，以解决与这些问题有关的具体研究优先级。由于这些目标，预计会议将颁布尖端信息，这些信息将促进新发现以改善健康和福祉。同样，作为一个更切实的产出，组织委员会计划在本次会议之后制定要提交的评论文章。根据会议，演讲和讨论，组织者将根据本次会议评估更扩展的研究和/或审查文章的潜力，并评估有关此主题的未来会议的潜力。